My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 263

    1.

    Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2005 May 17;142(10):855-60.PMID: 15897536 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Postmenopausal hormone replacement therapy for primary prevention of chronic conditions: recommendations and rationale.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2002 Nov 19;137(10):834-9.PMID: 12435221 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Hormone therapy to prevent chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force.

    [No authors listed]

    Ann Intern Med. 2005 May 17;142(10):I59. No abstract available. PMID: 15897529 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Summaries for patients. Postmenopausal hormone replacement therapy to prevent chronic conditions: recommendations from the U.S. Preventive Services Task Force.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2002 Nov 19;137(10):I48. No abstract available. PMID: 12435233 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Postmenopausal hormone replacement therapy for the primary prevention of chronic condition. Recommendations and rationale. U.S. Preventive Services Task Force.

    USPSTF.

    Am Fam Physician. 2003 Jan 15;67(2):358-64. No abstract available. PMID: 12562158 [PubMed - indexed for MEDLINE]Related articles

    6.

    Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2005 Sep 6;143(5):355-61. Review. Erratum in: Ann Intern Med. 2005 Oct 4;143(7):547. PMID: 16144894 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Screening for type 2 diabetes mellitus in adults: recommendations and rationale.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2003 Feb 4;138(3):212-4.PMID: 12558361 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Screening for coronary heart disease: recommendation statement.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2004 Apr 6;140(7):569-72.PMID: 15068986 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Screening for colorectal cancer: recommendation and rationale.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2002 Jul 16;137(2):129-31.PMID: 12118971 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?

    Mikkola TS, Clarkson TB, Notelovitz M.

    Ann Med. 2004;36(6):402-13. Review.PMID: 15513292 [PubMed - indexed for MEDLINE]Related articles

    11.

    Clinical appraisal of the Women's Health Initiative.

    Speroff L.

    J Obstet Gynaecol Res. 2005 Apr;31(2):80-93. Review. No abstract available. PMID: 15771632 [PubMed - indexed for MEDLINE]Related articles

    12.

    Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.

    Berg AO; U.S. Preventive Services Task Force.

    Am J Nurs. 2003 Jun;103(6):83-91. Review. No abstract available. PMID: 12802162 [PubMed - indexed for MEDLINE]Related articles

    13.

    Routine vitamin supplementation to prevent cancer and cardiovascular disease: recommendations and rationale.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2003 Jul 1;139(1):51-5.PMID: 12834319 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2007 Mar 6;146(5):361-4.PMID: 17339621 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Screening for obesity in adults: recommendations and rationale.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2003 Dec 2;139(11):930-2.PMID: 14644896 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Benefits of hormone replacement therapy in postmenopausal women.

    Canderelli R, Leccesse LA, Miller NL, Unruh Davidson J.

    J Am Acad Nurse Pract. 2007 Dec;19(12):635-41. Review.PMID: 18042129 [PubMed - indexed for MEDLINE]Related articles

    17.

    Screening for thyroid disease: recommendation statement.

    U.S. Preventive Services Task Force.

    Ann Intern Med. 2004 Jan 20;140(2):125-7.PMID: 14734336 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    American College of Preventive Medicine Practice Policy Statement: perimenopausal and postmenopausal hormone replacement therapy.

    Nawaz H, Katz DL.

    Am J Prev Med. 1999 Oct;17(3):250-4.PMID: 10987643 [PubMed - indexed for MEDLINE]Related articles

    19.

    Lessons from the skeleton: was the Women's Health Initiative (WHI) a primary prevention trial?

    Kleerekoper M.

    Osteoporos Int. 2002 Sep;13(9):685-7. No abstract available. PMID: 12195531 [PubMed - indexed for MEDLINE]Related articles

    20.

    Making decisions about hormone replacement therapy.

    Rymer J, Wilson R, Ballard K.

    BMJ. 2003 Feb 8;326(7384):322-6. Review. No abstract available. PMID: 12574048 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity